Article Versions Notes

Herrera F, Torres D, Laborde A, Jordán R, Mañez N, Berruezo L, Lambert S, Suchowiercha N, Costantini P, Nenna A, et al. Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Bacteremia. Microorganisms. 2024; 12(1):195. https://doi.org/10.3390/microorganisms12010195

Herrera, Fabián, Diego Torres, Ana Laborde, Rosana Jordán, Noelia Mañez, Lorena Berruezo, Sandra Lambert, Nadia Suchowiercha, Patricia Costantini, Andrea Nenna, and et al. 2024. "Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Bacteremia" Microorganisms 12, no. 1: 195. https://doi.org/10.3390/microorganisms12010195

Herrera, F., Torres, D., Laborde, A., Jordán, R., Mañez, N., Berruezo, L., Lambert, S., Suchowiercha, N., Costantini, P., Nenna, A., Pereyra, M. L., Benso, J., González Ibañez, M. L., Eusebio, M. J., Barcán, L., Baldoni, N., Tula, L., Roccia Rossi, I., Luck, M., ... Carena, A. Á., on behalf of the Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS) Study. (2024). Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Bacteremia. Microorganisms, 12(1), 195. https://doi.org/10.3390/microorganisms12010195